X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (169) 169
humans (148) 148
ophthalmology (122) 122
female (70) 70
male (69) 69
aged (66) 66
middle aged (60) 60
visual acuity (53) 53
adult (44) 44
medicine, general & internal (38) 38
fluorescein angiography (31) 31
aged, 80 and over (27) 27
macular degeneration (27) 27
optical coherence tomography (25) 25
randomized controlled trials as topic (24) 24
follow-up studies (22) 22
retina (22) 22
retrospective studies (22) 22
surgery (22) 22
treatment outcome (22) 22
visual acuity - physiology (22) 22
fundus oculi (21) 21
reproducibility of results (21) 21
eye diseases (20) 20
abridged index medicus (19) 19
medicine & public health (19) 19
adolescent (17) 17
diabetic retinopathy (17) 17
prevalence (17) 17
tomography, optical coherence - methods (17) 17
bias (16) 16
glaucoma (16) 16
tomography, optical coherence (16) 16
analysis (15) 15
genetic structures (15) 15
photodynamic therapy (15) 15
prospective studies (15) 15
ranibizumab (15) 15
child (14) 14
choroidal neovascularization - drug therapy (14) 14
diabetic retinopathy - complications (14) 14
studies (14) 14
choroidal neovascularization - etiology (13) 13
photochemotherapy (13) 13
photosensitizing agents - therapeutic use (13) 13
research (13) 13
tomography (13) 13
accuracy (12) 12
angiogenesis inhibitors - therapeutic use (12) 12
bevacizumab (12) 12
laser coagulation - methods (12) 12
medical imaging (12) 12
vitrectomy (12) 12
care and treatment (11) 11
eye (11) 11
eyes (11) 11
internal medicine (11) 11
macular degeneration - complications (11) 11
patients (11) 11
sensitivity and specificity (11) 11
systematic review (11) 11
visual impairment (11) 11
article (10) 10
choroidal neovascularization (10) 10
degeneration (10) 10
porphyrins - therapeutic use (10) 10
reading (10) 10
research article (10) 10
vascular endothelial growth factor a - antagonists & inhibitors (10) 10
young adult (10) 10
age (9) 9
clinical trials (9) 9
disease (9) 9
epidemiology (9) 9
maculopathy (9) 9
myopia (9) 9
retinopathy (9) 9
risk factors (9) 9
science (9) 9
visual-acuity (9) 9
acuity (8) 8
choroidal neovascularization - diagnosis (8) 8
diabetes (8) 8
diagnosis (8) 8
intravitreal injections (8) 8
macular degeneration - diagnosis (8) 8
macular degeneration - physiopathology (8) 8
medicine (8) 8
membranes (8) 8
multidisciplinary sciences (8) 8
mutation (8) 8
mutations (8) 8
outcomes (8) 8
physiological aspects (8) 8
retina - pathology (8) 8
safety (8) 8
sense organs (8) 8
time factors (8) 8
age-related macular degeneration (7) 7
choroidal neovascularization - physiopathology (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Ophthalmology, ISSN 2168-6165, 11/2018, Volume 136, Issue 11, p. 1225
Virgili et al reflect on the study by Lindsley et al which present the results of a prioritization process aiming to build on the existing American Academy of... 
Macular degeneration | Myopia | Presbyopia | Degeneration | Ophthalmology | Hyperopia | Age
Journal Article
Eye (Basingstoke), ISSN 0950-222X, 2019, Volume 33, Issue 6, pp. 882 - 886
In 1972, Archie Cochrane wrote “It is surely a great criticism of our profession that we have not organised a critical summary, by specialty or subspecialty,... 
Eye | Visual impairment | Vision | Blindness | Clinical trials | Systematic review | Patients
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 05/2014, Volume 160, Issue 10, pp. 704 - 711
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 10/2017, Volume 182, pp. xii - xiv
Journal Article
Cochrane Database of Systematic Reviews, 08/2014, Volume 2014, Issue 8
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, pp. e0121857 - e0121857
Total serum IgE result from the combination of specific and non-specific pools. High specific/total IgE ratio may reflect high level of allergen-specific IgE... 
MARKERS | DIAGNOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | IMMUNOGLOBULIN-E | Young Adult | beta-Lactams - blood | beta-Lactams - pharmacology | Humans | Middle Aged | Adolescent | Adult | Female | Male | Immunoglobulin E - blood | Allergens | Antibodies | Immunoglobulin E | Likelihood ratio | Data processing | Criteria | Patients | Allergies | Antibiotics | Simulation | Skin | Diagnostic systems | Mast cells | Skin tests | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007419 - CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | Quality of Life | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy | Index Medicus
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 02/2019, Volume 198, pp. 8 - 16
To investigate the progression of diabetic microaneurysms (MAs) according to the spectral-domain optical coherence tomography (SD-OCT) and OCT angiography... 
OPHTHALMOLOGY | SIGNIFICANT MACULAR EDEMA | RETINOPATHY | EYES | TURNOVER | ASSOCIATION | Edema | Diabetic retinopathy | Medical imaging | Tomography | Software | Photographs | Diabetes | Ophthalmology
Journal Article
JAMA OPHTHALMOLOGY, ISSN 2168-6165, 06/2019, Volume 137, Issue 6, pp. 694 - 697
ImportanceCataract surgery, with intraocular lens (IOL) implantation, is the most common ocular surgical procedure worldwide. It has been suggested that IOLs... 
OPHTHALMOLOGY | RANDOMIZED CONTROLLED-TRIALS | INTERVENTIONS | CLINICAL-TRIALS | Cataracts | Demography | Clinical trials | Retina | Systematic review | Eye surgery | Macular degeneration | Reviews | Surgery | Light | Measurement techniques | Aging | Degeneration | Ophthalmology | Public health | Index Medicus | Abridged Index Medicus
Journal Article
Ophthalmic and Physiological Optics, ISSN 0275-5408, 09/2017, Volume 37, Issue 5, pp. 627 - 628
Journal Article
Journal Article
Journal Article